Calcium in PDB 5ney: Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Protein crystallography data
The structure of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa, PDB code: 5ney
was solved by
J.-L.Reymond,
T.Darbre,
A.Stocker,
W.Hong,
C.Van Delden,
T.Koehler,
A.Luscher,
R.Visini,
Y.Fu,
I.Di Bonaventura,
R.He,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
47.43 /
1.55
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
94.925,
45.748,
103.850,
90.00,
114.98,
90.00
|
R / Rfree (%)
|
18.5 /
21.7
|
Calcium Binding Sites:
The binding sites of Calcium atom in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
(pdb code 5ney). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 8 binding sites of Calcium where determined in the
Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa, PDB code: 5ney:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Calcium binding site 1 out
of 8 in 5ney
Go back to
Calcium Binding Sites List in 5ney
Calcium binding site 1 out
of 8 in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca202
b:13.5
occ:1.00
|
OD1
|
A:ASP101
|
2.3
|
11.4
|
1.0
|
OD2
|
A:ASP104
|
2.4
|
13.7
|
1.0
|
OD1
|
A:ASP99
|
2.4
|
15.1
|
1.0
|
O4
|
A:ZDC201
|
2.4
|
17.3
|
1.0
|
OE2
|
A:GLU95
|
2.4
|
13.8
|
1.0
|
O3
|
A:ZDC201
|
2.5
|
15.3
|
1.0
|
OE1
|
A:GLU95
|
2.5
|
13.3
|
1.0
|
OD1
|
A:ASP104
|
2.6
|
12.3
|
1.0
|
CD
|
A:GLU95
|
2.8
|
12.3
|
1.0
|
CG
|
A:ASP104
|
2.9
|
12.8
|
1.0
|
C4
|
A:ZDC201
|
3.2
|
15.8
|
1.0
|
C3
|
A:ZDC201
|
3.3
|
13.8
|
1.0
|
CG
|
A:ASP101
|
3.4
|
13.8
|
1.0
|
CG
|
A:ASP99
|
3.4
|
18.8
|
1.0
|
CA
|
A:CA203
|
3.7
|
14.1
|
1.0
|
OD2
|
A:ASP99
|
3.7
|
20.6
|
1.0
|
OD2
|
A:ASP101
|
3.9
|
16.2
|
1.0
|
O
|
A:HOH341
|
4.0
|
24.4
|
1.0
|
N
|
A:ASP101
|
4.1
|
15.7
|
1.0
|
OD1
|
A:ASP96
|
4.2
|
15.2
|
1.0
|
CG
|
A:GLU95
|
4.3
|
13.2
|
1.0
|
CB
|
A:ASP104
|
4.4
|
13.8
|
1.0
|
N
|
A:ASN100
|
4.4
|
17.7
|
1.0
|
N
|
A:TYR102
|
4.5
|
12.1
|
1.0
|
N
|
A:ASP96
|
4.5
|
12.7
|
1.0
|
CB
|
A:ASP101
|
4.6
|
18.2
|
1.0
|
N
|
A:GLY97
|
4.6
|
16.4
|
1.0
|
C5
|
A:ZDC201
|
4.7
|
33.0
|
1.0
|
C2
|
A:ZDC201
|
4.7
|
19.1
|
1.0
|
OD1
|
A:ASN103
|
4.7
|
13.4
|
1.0
|
CA
|
A:GLU95
|
4.7
|
14.1
|
1.0
|
CA
|
A:ASP101
|
4.7
|
15.0
|
1.0
|
CB
|
A:ASP99
|
4.8
|
17.6
|
1.0
|
O2
|
A:ZDC201
|
4.8
|
16.4
|
1.0
|
N
|
A:ASP99
|
4.8
|
16.6
|
1.0
|
CB
|
A:GLU95
|
4.9
|
9.9
|
1.0
|
CG
|
A:ASP96
|
4.9
|
13.6
|
1.0
|
C
|
A:ASP99
|
5.0
|
16.4
|
1.0
|
C
|
A:ASP101
|
5.0
|
17.2
|
1.0
|
CA
|
A:ASN100
|
5.0
|
19.0
|
1.0
|
|
Calcium binding site 2 out
of 8 in 5ney
Go back to
Calcium Binding Sites List in 5ney
Calcium binding site 2 out
of 8 in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca203
b:14.1
occ:1.00
|
OD1
|
A:ASN103
|
2.3
|
13.4
|
1.0
|
OD1
|
A:ASP104
|
2.3
|
12.3
|
1.0
|
O
|
A:ASN21
|
2.4
|
14.6
|
1.0
|
OD2
|
A:ASP101
|
2.4
|
16.2
|
1.0
|
O2
|
A:ZDC201
|
2.4
|
16.4
|
1.0
|
O3
|
A:ZDC201
|
2.4
|
15.3
|
1.0
|
O
|
D:GLY114
|
2.5
|
14.8
|
1.0
|
OD1
|
A:ASP101
|
3.0
|
11.4
|
1.0
|
CG
|
A:ASP101
|
3.0
|
13.8
|
1.0
|
C3
|
A:ZDC201
|
3.3
|
13.8
|
1.0
|
C2
|
A:ZDC201
|
3.3
|
19.1
|
1.0
|
CG
|
A:ASN103
|
3.4
|
14.7
|
1.0
|
C
|
D:GLY114
|
3.5
|
21.2
|
1.0
|
C
|
A:ASN21
|
3.5
|
14.6
|
1.0
|
CG
|
A:ASP104
|
3.6
|
12.8
|
1.0
|
OXT
|
D:GLY114
|
3.7
|
20.3
|
1.0
|
CA
|
A:CA202
|
3.7
|
13.5
|
1.0
|
C4
|
A:ZDC201
|
3.8
|
15.8
|
1.0
|
ND2
|
A:ASN103
|
3.8
|
14.6
|
1.0
|
CA
|
A:ASP104
|
4.2
|
10.3
|
1.0
|
CB
|
A:ASN21
|
4.2
|
14.3
|
1.0
|
N
|
A:ASP104
|
4.3
|
10.0
|
1.0
|
CA
|
A:SER22
|
4.4
|
16.4
|
1.0
|
N
|
A:SER22
|
4.4
|
12.2
|
1.0
|
OD2
|
A:ASP104
|
4.4
|
13.7
|
1.0
|
CB
|
A:ASP104
|
4.4
|
13.8
|
1.0
|
O4
|
A:ZDC201
|
4.5
|
17.3
|
1.0
|
C
|
A:ASN103
|
4.5
|
10.1
|
1.0
|
CB
|
A:ASP101
|
4.5
|
18.2
|
1.0
|
CA
|
A:ASN21
|
4.5
|
12.6
|
1.0
|
OD2
|
A:ASP99
|
4.5
|
20.6
|
1.0
|
CB
|
A:SER22
|
4.6
|
21.8
|
1.0
|
C1
|
A:ZDC201
|
4.7
|
28.9
|
1.0
|
O
|
D:HOH333
|
4.7
|
28.1
|
1.0
|
CB
|
A:ASN103
|
4.7
|
10.2
|
1.0
|
O
|
A:ASN103
|
4.8
|
13.2
|
1.0
|
CA
|
D:GLY114
|
4.8
|
16.1
|
1.0
|
N
|
A:ASN103
|
4.9
|
13.8
|
1.0
|
CA
|
A:ASN103
|
4.9
|
10.6
|
1.0
|
|
Calcium binding site 3 out
of 8 in 5ney
Go back to
Calcium Binding Sites List in 5ney
Calcium binding site 3 out
of 8 in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca301
b:13.2
occ:1.00
|
OD2
|
B:ASP104
|
2.3
|
11.8
|
1.0
|
OD1
|
B:ASP99
|
2.4
|
19.6
|
1.0
|
OD1
|
B:ASP101
|
2.4
|
11.3
|
1.0
|
OE2
|
B:GLU95
|
2.4
|
16.5
|
1.0
|
O3
|
E:ZDC201
|
2.5
|
16.6
|
1.0
|
O4
|
E:ZDC201
|
2.5
|
11.1
|
1.0
|
OE1
|
B:GLU95
|
2.6
|
12.7
|
1.0
|
OD1
|
B:ASP104
|
2.6
|
11.2
|
1.0
|
CD
|
B:GLU95
|
2.8
|
13.9
|
1.0
|
CG
|
B:ASP104
|
2.8
|
10.8
|
1.0
|
C4
|
E:ZDC201
|
3.3
|
10.3
|
1.0
|
C3
|
E:ZDC201
|
3.3
|
14.0
|
1.0
|
CG
|
B:ASP99
|
3.3
|
17.3
|
1.0
|
CG
|
B:ASP101
|
3.5
|
12.4
|
1.0
|
OD2
|
B:ASP99
|
3.6
|
16.4
|
1.0
|
CA
|
B:CA302
|
3.7
|
13.4
|
1.0
|
OD2
|
B:ASP101
|
4.0
|
14.1
|
1.0
|
OD1
|
B:ASP96
|
4.1
|
15.3
|
1.0
|
N
|
B:ASP101
|
4.2
|
15.4
|
1.0
|
O
|
E:HOH305
|
4.3
|
22.4
|
1.0
|
CG
|
B:GLU95
|
4.3
|
12.5
|
1.0
|
CB
|
B:ASP104
|
4.3
|
12.1
|
1.0
|
N
|
B:ASN100
|
4.4
|
14.5
|
1.0
|
N
|
B:TYR102
|
4.5
|
12.4
|
1.0
|
N
|
B:ASP96
|
4.5
|
12.8
|
1.0
|
N
|
B:GLY97
|
4.6
|
13.9
|
1.0
|
CB
|
B:ASP101
|
4.6
|
15.9
|
1.0
|
C5
|
E:ZDC201
|
4.7
|
19.2
|
1.0
|
C2
|
E:ZDC201
|
4.7
|
14.1
|
1.0
|
CA
|
B:GLU95
|
4.7
|
10.7
|
1.0
|
CB
|
B:ASP99
|
4.7
|
17.2
|
1.0
|
OD1
|
B:ASN103
|
4.7
|
10.5
|
1.0
|
N
|
B:ASP99
|
4.8
|
16.3
|
1.0
|
CA
|
B:ASP101
|
4.8
|
15.0
|
1.0
|
O2
|
E:ZDC201
|
4.9
|
13.7
|
1.0
|
CG
|
B:ASP96
|
4.9
|
14.0
|
1.0
|
CB
|
B:GLU95
|
5.0
|
11.6
|
1.0
|
C
|
B:ASP99
|
5.0
|
17.5
|
1.0
|
|
Calcium binding site 4 out
of 8 in 5ney
Go back to
Calcium Binding Sites List in 5ney
Calcium binding site 4 out
of 8 in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca302
b:13.4
occ:1.00
|
OD1
|
B:ASN103
|
2.4
|
10.5
|
1.0
|
OD1
|
B:ASP104
|
2.4
|
11.2
|
1.0
|
O
|
B:ASN21
|
2.4
|
12.5
|
1.0
|
O
|
C:GLY114
|
2.4
|
14.1
|
1.0
|
O3
|
E:ZDC201
|
2.4
|
16.6
|
1.0
|
OD2
|
B:ASP101
|
2.5
|
14.1
|
1.0
|
O2
|
E:ZDC201
|
2.5
|
13.7
|
1.0
|
OD1
|
B:ASP101
|
3.0
|
11.3
|
1.0
|
CG
|
B:ASP101
|
3.1
|
12.4
|
1.0
|
C3
|
E:ZDC201
|
3.3
|
14.0
|
1.0
|
CG
|
B:ASN103
|
3.4
|
11.6
|
1.0
|
C2
|
E:ZDC201
|
3.4
|
14.1
|
1.0
|
C
|
C:GLY114
|
3.4
|
16.8
|
1.0
|
CG
|
B:ASP104
|
3.6
|
10.8
|
1.0
|
C
|
B:ASN21
|
3.6
|
12.1
|
1.0
|
OXT
|
C:GLY114
|
3.6
|
18.0
|
1.0
|
C4
|
E:ZDC201
|
3.7
|
10.3
|
1.0
|
CA
|
B:CA301
|
3.7
|
13.2
|
1.0
|
ND2
|
B:ASN103
|
3.8
|
12.1
|
1.0
|
CB
|
B:ASN21
|
4.2
|
11.3
|
1.0
|
CA
|
B:ASP104
|
4.2
|
12.9
|
1.0
|
N
|
B:ASP104
|
4.3
|
11.9
|
1.0
|
O4
|
E:ZDC201
|
4.4
|
11.1
|
1.0
|
CA
|
B:SER22
|
4.4
|
15.1
|
1.0
|
OD2
|
B:ASP104
|
4.4
|
11.8
|
1.0
|
CB
|
B:ASP104
|
4.4
|
12.1
|
1.0
|
N
|
B:SER22
|
4.5
|
14.7
|
1.0
|
OD2
|
B:ASP99
|
4.5
|
16.4
|
1.0
|
C
|
B:ASN103
|
4.5
|
15.6
|
1.0
|
CA
|
B:ASN21
|
4.5
|
14.1
|
1.0
|
O
|
B:HOH442
|
4.6
|
24.8
|
1.0
|
CB
|
B:ASP101
|
4.6
|
15.9
|
1.0
|
CB
|
B:SER22
|
4.6
|
12.7
|
1.0
|
C1
|
E:ZDC201
|
4.7
|
19.6
|
1.0
|
CB
|
B:ASN103
|
4.8
|
11.4
|
1.0
|
CA
|
C:GLY114
|
4.8
|
16.1
|
1.0
|
O
|
B:ASN103
|
4.8
|
12.8
|
1.0
|
N
|
B:ASN103
|
4.9
|
11.6
|
1.0
|
CA
|
B:ASN103
|
5.0
|
11.6
|
1.0
|
O5
|
E:ZDC201
|
5.0
|
21.7
|
1.0
|
C5
|
E:ZDC201
|
5.0
|
19.2
|
1.0
|
|
Calcium binding site 5 out
of 8 in 5ney
Go back to
Calcium Binding Sites List in 5ney
Calcium binding site 5 out
of 8 in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Ca202
b:15.2
occ:1.00
|
OD1
|
C:ASP99
|
2.4
|
18.6
|
1.0
|
OD1
|
C:ASP101
|
2.4
|
13.7
|
1.0
|
O4
|
C:ZDC201
|
2.4
|
15.2
|
1.0
|
OE2
|
C:GLU95
|
2.4
|
15.2
|
1.0
|
O3
|
C:ZDC201
|
2.5
|
16.6
|
1.0
|
OD2
|
C:ASP104
|
2.5
|
11.9
|
1.0
|
OE1
|
C:GLU95
|
2.5
|
14.8
|
1.0
|
OD1
|
C:ASP104
|
2.7
|
13.0
|
1.0
|
CD
|
C:GLU95
|
2.8
|
14.7
|
1.0
|
CG
|
C:ASP104
|
2.9
|
10.2
|
1.0
|
C4
|
C:ZDC201
|
3.2
|
20.6
|
1.0
|
C3
|
C:ZDC201
|
3.4
|
19.4
|
1.0
|
CG
|
C:ASP99
|
3.4
|
15.2
|
1.0
|
CG
|
C:ASP101
|
3.4
|
13.1
|
1.0
|
OD2
|
C:ASP99
|
3.6
|
20.0
|
1.0
|
CA
|
C:CA203
|
3.7
|
14.8
|
1.0
|
OD2
|
C:ASP101
|
3.9
|
17.8
|
1.0
|
O
|
C:HOH354
|
4.0
|
20.6
|
1.0
|
N
|
C:ASP101
|
4.0
|
15.4
|
1.0
|
CG
|
C:GLU95
|
4.3
|
13.7
|
1.0
|
OD1
|
C:ASP96
|
4.3
|
16.3
|
1.0
|
CB
|
C:ASP104
|
4.4
|
12.1
|
1.0
|
N
|
C:ASN100
|
4.5
|
17.2
|
1.0
|
N
|
C:TYR102
|
4.5
|
12.3
|
1.0
|
N
|
C:ASP96
|
4.5
|
14.4
|
1.0
|
CB
|
C:ASP101
|
4.5
|
13.9
|
1.0
|
N
|
C:GLY97
|
4.6
|
15.8
|
1.0
|
C2
|
C:ZDC201
|
4.7
|
19.7
|
1.0
|
C5
|
C:ZDC201
|
4.7
|
38.6
|
1.0
|
O2
|
C:ZDC201
|
4.7
|
13.4
|
1.0
|
CA
|
C:ASP101
|
4.7
|
13.0
|
1.0
|
OD1
|
C:ASN103
|
4.7
|
11.1
|
1.0
|
CB
|
C:ASP99
|
4.7
|
21.0
|
1.0
|
CA
|
C:GLU95
|
4.7
|
13.3
|
1.0
|
N
|
C:ASP99
|
4.8
|
16.2
|
1.0
|
C
|
C:ASP101
|
4.9
|
15.3
|
1.0
|
CB
|
C:GLU95
|
5.0
|
15.5
|
1.0
|
C
|
C:ASP99
|
5.0
|
17.4
|
1.0
|
|
Calcium binding site 6 out
of 8 in 5ney
Go back to
Calcium Binding Sites List in 5ney
Calcium binding site 6 out
of 8 in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Ca203
b:14.8
occ:1.00
|
OD1
|
C:ASN103
|
2.3
|
11.1
|
1.0
|
O
|
C:ASN21
|
2.4
|
13.9
|
1.0
|
O2
|
C:ZDC201
|
2.4
|
13.4
|
1.0
|
O
|
B:GLY114
|
2.4
|
14.6
|
1.0
|
OD1
|
C:ASP104
|
2.4
|
13.0
|
1.0
|
OD2
|
C:ASP101
|
2.4
|
17.8
|
1.0
|
O3
|
C:ZDC201
|
2.5
|
16.6
|
1.0
|
OD1
|
C:ASP101
|
3.0
|
13.7
|
1.0
|
CG
|
C:ASP101
|
3.1
|
13.1
|
1.0
|
CG
|
C:ASN103
|
3.4
|
13.3
|
1.0
|
C
|
B:GLY114
|
3.4
|
18.6
|
1.0
|
C2
|
C:ZDC201
|
3.4
|
19.7
|
1.0
|
C3
|
C:ZDC201
|
3.4
|
19.4
|
1.0
|
OXT
|
B:GLY114
|
3.6
|
20.5
|
1.0
|
C
|
C:ASN21
|
3.6
|
15.6
|
1.0
|
CG
|
C:ASP104
|
3.6
|
10.2
|
1.0
|
CA
|
C:CA202
|
3.7
|
15.2
|
1.0
|
ND2
|
C:ASN103
|
3.8
|
13.7
|
1.0
|
C4
|
C:ZDC201
|
3.9
|
20.6
|
1.0
|
CA
|
C:ASP104
|
4.2
|
11.5
|
1.0
|
CB
|
C:ASN21
|
4.2
|
12.6
|
1.0
|
N
|
C:ASP104
|
4.2
|
11.1
|
1.0
|
CA
|
C:SER22
|
4.4
|
11.6
|
1.0
|
N
|
C:SER22
|
4.4
|
14.7
|
1.0
|
C
|
C:ASN103
|
4.5
|
9.4
|
1.0
|
O4
|
C:ZDC201
|
4.5
|
15.2
|
1.0
|
OD2
|
C:ASP104
|
4.5
|
11.9
|
1.0
|
CB
|
C:ASP104
|
4.5
|
12.1
|
1.0
|
OD2
|
C:ASP99
|
4.5
|
20.0
|
1.0
|
CB
|
C:ASP101
|
4.5
|
13.9
|
1.0
|
CA
|
C:ASN21
|
4.6
|
9.2
|
1.0
|
CB
|
C:SER22
|
4.6
|
18.3
|
1.0
|
O
|
C:HOH363
|
4.7
|
24.1
|
1.0
|
CB
|
C:ASN103
|
4.7
|
13.3
|
1.0
|
C1
|
C:ZDC201
|
4.7
|
42.8
|
1.0
|
CA
|
B:GLY114
|
4.8
|
15.8
|
1.0
|
O
|
C:ASN103
|
4.8
|
12.1
|
1.0
|
N
|
C:ASN103
|
4.9
|
12.7
|
1.0
|
CA
|
C:ASN103
|
4.9
|
11.9
|
1.0
|
|
Calcium binding site 7 out
of 8 in 5ney
Go back to
Calcium Binding Sites List in 5ney
Calcium binding site 7 out
of 8 in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 7 of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Ca202
b:17.0
occ:1.00
|
OD1
|
D:ASP101
|
2.3
|
13.6
|
1.0
|
OD1
|
D:ASP99
|
2.4
|
20.4
|
1.0
|
OD2
|
D:ASP104
|
2.4
|
16.8
|
1.0
|
OE2
|
D:GLU95
|
2.4
|
19.5
|
1.0
|
O4
|
D:ZDC201
|
2.4
|
18.9
|
1.0
|
O3
|
D:ZDC201
|
2.4
|
15.8
|
1.0
|
OE1
|
D:GLU95
|
2.5
|
17.7
|
1.0
|
OD1
|
D:ASP104
|
2.6
|
14.6
|
1.0
|
CD
|
D:GLU95
|
2.8
|
16.5
|
1.0
|
CG
|
D:ASP104
|
2.8
|
14.2
|
1.0
|
C4
|
D:ZDC201
|
3.3
|
16.2
|
1.0
|
CG
|
D:ASP101
|
3.4
|
13.5
|
1.0
|
C3
|
D:ZDC201
|
3.4
|
16.2
|
1.0
|
CG
|
D:ASP99
|
3.4
|
18.6
|
1.0
|
CA
|
D:CA203
|
3.7
|
15.6
|
1.0
|
OD2
|
D:ASP99
|
3.7
|
20.7
|
1.0
|
OD2
|
D:ASP101
|
4.0
|
15.0
|
1.0
|
O
|
D:HOH355
|
4.0
|
22.0
|
1.0
|
N
|
D:ASP101
|
4.0
|
15.2
|
1.0
|
CG
|
D:GLU95
|
4.3
|
16.6
|
1.0
|
OD1
|
D:ASP96
|
4.3
|
20.9
|
1.0
|
CB
|
D:ASP104
|
4.4
|
12.1
|
1.0
|
N
|
D:TYR102
|
4.4
|
15.1
|
1.0
|
N
|
D:ASN100
|
4.5
|
17.4
|
1.0
|
N
|
D:GLY97
|
4.5
|
19.3
|
1.0
|
N
|
D:ASP96
|
4.5
|
16.7
|
1.0
|
CB
|
D:ASP101
|
4.5
|
14.1
|
1.0
|
OD1
|
D:ASN103
|
4.6
|
13.6
|
1.0
|
CA
|
D:ASP101
|
4.7
|
16.5
|
1.0
|
C2
|
D:ZDC201
|
4.7
|
17.8
|
1.0
|
C5
|
D:ZDC201
|
4.7
|
36.6
|
1.0
|
CA
|
D:GLU95
|
4.7
|
14.5
|
1.0
|
N
|
D:ASP99
|
4.8
|
19.0
|
1.0
|
CB
|
D:ASP99
|
4.8
|
21.4
|
1.0
|
O2
|
D:ZDC201
|
4.8
|
18.3
|
1.0
|
C
|
D:ASP101
|
4.9
|
15.1
|
1.0
|
CG
|
D:ASP96
|
4.9
|
14.6
|
1.0
|
CB
|
D:GLU95
|
5.0
|
13.1
|
1.0
|
C
|
D:ASP99
|
5.0
|
16.8
|
1.0
|
|
Calcium binding site 8 out
of 8 in 5ney
Go back to
Calcium Binding Sites List in 5ney
Calcium binding site 8 out
of 8 in the Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 8 of Discovery, Crystal Structures and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Ca203
b:15.6
occ:1.00
|
OD1
|
D:ASN103
|
2.3
|
13.6
|
1.0
|
OD1
|
D:ASP104
|
2.4
|
14.6
|
1.0
|
O
|
D:ASN21
|
2.4
|
15.0
|
1.0
|
O2
|
D:ZDC201
|
2.5
|
18.3
|
1.0
|
O
|
A:GLY114
|
2.5
|
18.1
|
1.0
|
O3
|
D:ZDC201
|
2.5
|
15.8
|
1.0
|
OD2
|
D:ASP101
|
2.5
|
15.0
|
1.0
|
OD1
|
D:ASP101
|
3.0
|
13.6
|
1.0
|
CG
|
D:ASP101
|
3.1
|
13.5
|
1.0
|
CG
|
D:ASN103
|
3.4
|
13.8
|
1.0
|
C3
|
D:ZDC201
|
3.4
|
16.2
|
1.0
|
C
|
A:GLY114
|
3.4
|
21.6
|
1.0
|
C2
|
D:ZDC201
|
3.4
|
17.8
|
1.0
|
CG
|
D:ASP104
|
3.6
|
14.2
|
1.0
|
OXT
|
A:GLY114
|
3.6
|
21.4
|
1.0
|
C
|
D:ASN21
|
3.6
|
13.9
|
1.0
|
CA
|
D:CA202
|
3.7
|
17.0
|
1.0
|
ND2
|
D:ASN103
|
3.8
|
14.7
|
1.0
|
C4
|
D:ZDC201
|
3.8
|
16.2
|
1.0
|
CB
|
D:ASN21
|
4.2
|
11.8
|
1.0
|
CA
|
D:ASP104
|
4.2
|
14.1
|
1.0
|
N
|
D:ASP104
|
4.2
|
12.9
|
1.0
|
O4
|
D:ZDC201
|
4.4
|
18.9
|
1.0
|
OD2
|
D:ASP104
|
4.4
|
16.8
|
1.0
|
CB
|
D:ASP104
|
4.4
|
12.1
|
1.0
|
C
|
D:ASN103
|
4.5
|
14.1
|
1.0
|
N
|
D:SER22
|
4.5
|
14.1
|
1.0
|
OD2
|
D:ASP99
|
4.5
|
20.7
|
1.0
|
CA
|
D:ASN21
|
4.6
|
12.9
|
1.0
|
CA
|
D:SER22
|
4.6
|
14.7
|
1.0
|
CB
|
D:ASP101
|
4.6
|
14.1
|
1.0
|
O
|
A:HOH332
|
4.7
|
24.9
|
1.0
|
CB
|
D:ASN103
|
4.7
|
11.3
|
1.0
|
C1
|
D:ZDC201
|
4.8
|
43.0
|
1.0
|
CA
|
A:GLY114
|
4.8
|
13.3
|
1.0
|
O
|
D:ASN103
|
4.8
|
12.8
|
1.0
|
CB
|
D:SER22
|
4.8
|
16.9
|
1.0
|
N
|
D:ASN103
|
4.9
|
13.2
|
1.0
|
CA
|
D:ASN103
|
5.0
|
14.6
|
1.0
|
|
Reference:
R.He,
I.Di Bonaventura,
R.Visini,
B.H.Gan,
Y.Fu,
D.Probst,
A.Luscher,
T.Kohler,
C.Van Delden,
A.Stocker,
W.Hong,
T.Darbre,
J.L.Reymond.
Design, Crystal Structure and Atomic Force Microscopy Study of Thioether Ligated D,L-Cyclic Antimicrobial Peptides Against Multidrug Resistant Pseudomonas Aeruginosa. Chem Sci V. 8 7464 2017.
ISSN: ISSN 2041-6520
PubMed: 29163899
DOI: 10.1039/C7SC01599B
Page generated: Mon Jul 15 08:58:04 2024
|